Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study-Reference-Cited by-同舟云学术

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study

Author:

Cançado Rodolfo¹,Melo Murilo R.²,de Moraes Bastos Roberto³,Santos Paulo C. J. L.⁴,Guerra-Shinohara Elivira M.⁵,Chiattone Carlos¹,Ballas Samir K.⁶

Affiliation:

1. Department of Hematology/Oncology; Santa Casa Medical School; Sao Paulo Brazil

2. Molecular Medicine Laboratory; Santa Casa Medical School; Sao Paolo Brazil

3. Radiology Department; Santa Casa Medical School; Sao Paolo Brazil

4. Laboratory of Genetics and Molecular Cardiology; Heart Institute (InC0r); University of Sao Paolo Medical School; Sao Paolo Brazil

5. Department of Clinical Chemistry and Toxicology; Pharmaceutical Sciences School; University of Sao Paolo; Sao Paolo Brazil

6. Cardeza Foundation for Hematological Research Jefferson Medical College; Thomas Jefferson University Philadelphia; Philadelphia PA USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

Reference30 articles.

1. EASL clinical practice guidelines for HFE hemochromatosis;European Association for the Study of the Liver;J Hepatol,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献